Topics

GSK's Zejula slows disease progression in a range of ovarian cancers http://bit.ly/2ooWu8o  #OvarianCancer #cancer #pharmapic.twitter.com/7ZIage7H2E

14:30 EDT 2 Oct 2019 | Pharmafile

GSK's Zejula slows disease progression in a range of ovarian cancers http://bit.ly/2ooWu8o 

Original Article: GSK's Zejula slows disease progression in a range of ovarian cancers http://bit.ly/2ooWu8o  #OvarianCancer #cancer #pharmapic.twitter.com/7ZIage7H2E

NEXT ARTICLE

More From BioPortfolio on "GSK's Zejula slows disease progression in a range of ovarian cancers http://bit.ly/2ooWu8o  #OvarianCancer #cancer #pharmapic.twitter.com/7ZIage7H2E"

Quick Search

Relevant Topic

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...